ALLMedicine™ Membranous Glomerulonephritis Center

Apr 22nd, 2022 - Laboratory Studies Laboratory studies in patients with suspected membranous nephropathy are intended to evaluate the status of the kidneys and to search for an underlying cause. Tests include the following: Urine microscopy: Urine sediment is typi...

Apr 22nd, 2022 - Practice Essentials Membranous nephropathy (MGN) is the most common cause of nephrotic syndrome in the adult population, but also occurs in children. [1] Approximately 80% of MGN cases are idiopathic; the remainder are secondary (eg, to malignancy...

Apr 22nd, 2022 - History See the list below: Onset is insidious. Approximately 80% of patients describe edema. Patients may present with nonspecific complaints of anorexia, malaise, and fatigue. Some patients may present with asymptomatic proteinuria. Next: Physic...

Nov 23rd, 2021 - Practice Essentials Nephrotic syndrome is the combination of nephrotic-range proteinuria with a low serum albumin level and edema. Nephrotic-range proteinuria is the loss of 3 grams or more per day of protein into the urine or, on a single spot ur...

Nov 18th, 2021 - We describe two cases of acquired parathyroid hormone (PTH) resistance consequent to the development of serum PTH type 1 receptor (PTH1R) autoantibodies, which block PTH binding and signaling. Both cases were associated with other autoimmune manif...

Feb 25th, 2020 - Inflammatory bowel disease (IBD) is a chronic and relapsing inflammatory condition of the gastrointestinal tract. Crohn's disease and ulcerative colitis are the two principal types of IBD. The prevalence of IBD has been increasing worldwide . Extr...

Apr 8th, 2019 - To the Editor: We read with interest the case report of nephrogenic systemic fibrosis (NSF) by Chuang, Kaneshiro, and Betancourt in the June 2018 issue of Federal Practitioner. 1 It was reported that a 61-year-old Hispanic male patient with a histo.

May 30th, 2014 - The FDA has approved a new noninvasive test to help determine whether patients have primary membranous glomerulonephritis (pMGN). The Euroimmun Anti-PLA2R IFA blood test detects the antibody specific to pMGN, which helps determine whether patients...

May 30th, 2014 - The US Food and Drug Administration (FDA) has allowed marketing of the first noninvasive test for determining the cause of membranous glomerulonephritis (MGN). The test (EUROIMMUN Anti-PLA2R IFA, EUROIMMUN US, Inc) will help determine whether the ...

Clinical Manifestation Clinical features of HEV infection range from asymptomatic to acute hepatitis and even to acute or subacute liver failure.[5,29] HEV infection often follows a silent clinical course.[31] In symptomatic cases, jaundice, asthe...